Total Payments
$13,845
2024 Payments
$1,788
Companies
48
Transactions
871
Medicare Patients
3,685
Medicare Billing
$229,782
Payment Breakdown by Category
Food & Beverage$13,759 (99.4%)
Education$85.90 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,759 | 867 | 99.4% |
| Education | $85.90 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $2,077 | 163 | $0 (2024) |
| Amgen Inc. | $1,075 | 69 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $983.32 | 77 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $934.83 | 58 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $851.86 | 41 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $736.15 | 48 | $0 (2024) |
| Gilead Sciences, Inc. | $602.93 | 52 | $0 (2018) |
| PFIZER INC. | $578.48 | 45 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $570.54 | 28 | $0 (2024) |
| Novo Nordisk Inc | $557.01 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,788 | 106 | Novartis Pharmaceuticals Corporation ($308.53) |
| 2023 | $1,594 | 98 | E.R. Squibb & Sons, L.L.C. ($202.92) |
| 2022 | $2,188 | 127 | Janssen Pharmaceuticals, Inc ($340.05) |
| 2021 | $1,429 | 87 | Janssen Pharmaceuticals, Inc ($318.23) |
| 2020 | $634.79 | 40 | Kowa Pharmaceuticals America, Inc. ($140.17) |
| 2019 | $1,706 | 112 | Janssen Pharmaceuticals, Inc ($394.34) |
| 2018 | $2,404 | 155 | Kowa Pharmaceuticals America, Inc. ($329.26) |
| 2017 | $2,102 | 146 | Gilead Sciences Inc ($301.48) |
All Payment Transactions
871 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $11.30 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.31 | General |
| Category: Cardiovascular | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Obesity | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Obesity | ||||||
| 11/14/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: DIABETES | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.19 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.10 | General |
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.10 | General |
| Category: Cardiovascular | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Obesity | ||||||
| 09/23/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.74 | General |
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.95 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 850 | 1,089 | $106,364 | $51,326 |
| 2022 | 10 | 813 | 1,038 | $98,926 | $46,788 |
| 2021 | 11 | 956 | 1,196 | $150,923 | $68,871 |
| 2020 | 11 | 1,066 | 1,271 | $145,760 | $62,797 |
Total Patients
3,685
Total Services
4,594
Medicare Billing
$229,782
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 24 | $4,465 | $1,905 | 42.7% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 60 | 64 | $3,091 | $1,708 | 55.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $3,016 | $1,645 | 54.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 19 | $1,369 | $822.21 | 60.1% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 11 | 11 | $1,810 | $576.12 | 31.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2021 | 23 | 23 | $931.00 | $469.04 | 50.4% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2021 | 22 | 22 | $505.00 | $175.75 | 34.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 345 | 465 | $42,719 | $22,257 | 52.1% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 133 | 134 | $55,617 | $20,105 | 36.1% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 46 | 48 | $16,444 | $6,797 | 41.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 285 | 351 | $11,749 | $3,969 | 33.8% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 104 | 110 | $5,253 | $2,695 | 51.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $3,502 | $1,971 | 56.3% |
| 93308 | Follow-up or limited ultrasound examination of heart | Office | 2020 | 16 | 20 | $3,468 | $1,445 | 41.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 38 | 42 | $2,395 | $1,321 | 55.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 17 | $2,608 | $1,159 | 44.4% |
| 0298T | Review and interpretation of external ekg recording for more than 48 hours up to 21 days | Office | 2020 | 32 | 33 | $1,155 | $658.36 | 57.0% |
| 0296T | External ekg recording for more than 48 hours up to 21 days | Office | 2020 | 33 | 34 | $850.00 | $419.68 | 49.4% |
About Dr. Dewitt Leachman, M.D
Dr. Dewitt Leachman, M.D is a Cardiovascular Disease healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184647018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dewitt Leachman, M.D has received a total of $13,845 in payments from pharmaceutical and medical device companies, with $1,788 received in 2024. These payments were reported across 871 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($13,759).
As a Medicare-enrolled provider, Leachman has provided services to 3,685 Medicare beneficiaries, totaling 4,594 services with total Medicare billing of $229,782. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Specialist, Interventional Cardiology
- Location Houston, TX
- Active Since 07/25/2006
- Last Updated 01/23/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1184647018
Products in Payments
- XARELTO (Drug) $2,077
- ELIQUIS (Drug) $1,188
- Livalo (Drug) $837.78
- Corlanor (Drug) $595.81
- MULTAQ (Drug) $496.72
- ENTRESTO (Drug) $496.16
- Repatha (Biological) $479.08
- LEQVIO (Drug) $438.67
- Ozempic (Drug) $435.63
- OPSUMIT (Drug) $351.58
- VERQUVO (Drug) $298.30
- BYSTOLIC (Drug) $288.22
- LEXISCAN (Drug) $255.45
- Vascepa (Drug) $249.69
- PRALUENT (Drug) $239.43
- JARDIANCE (Drug) $232.52
- NEXLETOL (Drug) $225.47
- Optimizer (Device) $220.05
- KENGREAL (Drug) $216.76
- CAMZYOS (Drug) $194.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Houston
Reynolds Delgado, M.d, M.D
Cardiovascular Disease — Payments: $600,466
Cardiovascular Disease $600,466
Dr. Miguel Valderrabano, Md, MD
Cardiovascular Disease — Payments: $471,736
Cardiovascular Disease $471,736
Asif Ali, Md, MD
Cardiovascular Disease — Payments: $461,190
Cardiovascular Disease $461,190
Mr. Mehdi Razavi, Md, MD
Cardiovascular Disease — Payments: $433,792
Cardiovascular Disease $433,792
Dr. Michele Sartori, M.d, M.D
Cardiovascular Disease — Payments: $278,682
Cardiovascular Disease $278,682
Barry Trachtenberg, Md, MD
Cardiovascular Disease — Payments: $273,547
Cardiovascular Disease $273,547